Preview

Medical Genetics

Advanced search

Inborn disorders of tetrahydrobiopterin metabolism: clinical features and diagnosis

Abstract

Clinical cases of rare inborn neurometabolic diseases associated with tetrahydrobiopterin metabolic disorders are given. Such diseases are usually detected by mass neonatal screening for phenylketonuria, some of them are characterized by hyperphenylalaninemia. Effective treatment methods were developed for such diseases, diagnostic protocols for hyperphenylalaninemia were revised. We studied biopterin profile in blood and urine of 49 patients with hyperphenylalaninemia, and in 3 patients with tetrahydropterin-deficient syndrome. Clinical features and diagnostics were described.

About the Authors

N. A. Pichkur
Orphan Diseases Center, National Children’s Specialized Hospital «Okhmatdet» of Ministry of Health of Ukraine
Russian Federation


N. V. Ol`khovich
Orphan Diseases Center, National Children’s Specialized Hospital «Okhmatdet» of Ministry of Health of Ukraine
Russian Federation


N. S. Trofimova
Orphan Diseases Center, National Children’s Specialized Hospital «Okhmatdet» of Ministry of Health of Ukraine
Russian Federation


References

1. Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria // Lancet. - 2010. - Vol.376. - P.1417-1427.

2. Shintaku H. et al. Plasma biopterin levels and tetrahydrobiopterin responsiveness // Mol. Genet. Metab. - 2005. - Vol.86. - P.104-106.

3. Thony B., Blau N., Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterine synthase, sepiapterin reductase,carbinolamine-4a-dehydratase, and dihydropteredine reductase genes // Hum. Mutat. - 2006. - Vol.27. - P.870-878.

4. Blau N. et al. Disorders of tetrahydrobiopterin and related biogenic amines. In: The metabolic and molecular bases of inherited disease; eds. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, B. Vogelstain. - N.Y.: McGraw-Hill Med., 2001. - P.1725-1776.

5. Werner E.R. et al. Tetrahydrobiopterin: biochemistry and pathophysiology // Biochem. J. - 2011. - Vol.438. - P.397-414.

6. Longo N. Disorders of BH4 metabolism // J. Inherit. Metab. Dis. - 2009. - Vol.32. - P.333-342.

7. Bonafe L. et al. Mutations in the sepiapterin reductase reductase gene cause a novel tetrahydrobiopterin-dependent monoamine neurotransmitter deficiency without hyperphenylalaninemia // Am. J. Hum. Genet. - 2001. - Vol.69. - P.269-277.

8. Opladen T. et al. Clinical and biochemical characterization of patient with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia // Mov. Disord. - 2011. - Vol.26. - P.157-161.

9. Blau N., Thony B. Disorders of tetrahydrobiopterin metabolism. In: Pediatric endocrinology and inborn errors of metabolism; eds. K. Sarafoglou, G.F. Hoffmann, K.S. Roth. - N.Y.: McGraw-Hill Med., 2009. - P.170-175.

10. Opladen T., Hoffmann G.F., Blau N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia // J. Inherit. Metab. Dis. - 2012. - Vol.35, N6. - P.963-973.

11. Blau N. et al. Phenylketonuria and BH4 deficiencies. - Bremen: UNI-MED, 2010. - 1st Ed.

12. Smith I., Clayton B.E., Wolff O.H. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction // Lancet. - 1975. - Vol.1. - P.1108-1111.

13. Blau N. Genetics of phenylketonuria: then and now// J. Hum. Mut. - 2016. -Vol. 37, N. 6. - P. 508-515,

14. Blau N., Duran M., Gibson K.M. Laboratory guide to the methods in biochemical genetics. - Berlin - Heidelberg: Springer - Verlag, 2008. - P.665-684.

15. Burlina A., Blau N. Tetrahydrobiopterin disorders presenting with hyperphenylalaninemia. In: Congenital neurotransmitter disorders. A clinical approach; eds. Hoffmann G.F., Blau N. - N.Y.: Nova Biomedical., 2014. - P.39-51.

16. van Spronsen F.J., Hoeksma M., Reijngoud D.J. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause // J. Inherit. Metab. Dis. - 2009. - Vol.32, N1. - P.46-51.

17. Hoffmann G.F. Diseases of neurotransmission - from bench to bed. - Heilbron: SPS Verlagsgesellschaft, 2006. - P.45-55.

18. Luezzi V. et al. Phenotypic variability, neurological outcome and genetics background of 36 patients with 6-pyruvoyl-tetrahydropterine synthase deficiency // Clin. Genet. - 2010. - Vol.77. - P.249-257.

19. BIODEF-International Database of Tetrahydrobiopterin Deficiencies [Internet]; Available at: biopku.org: Databases of Pediatric Neurotransmitter Disorders inc. PKU www.biopku.org accessed May 2010.

20. Opladen T. et al. Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of method and 5 years’ experience // J. Inherit. Metab. Dis. - 2011. - Vol.34. - P.819-826.

21. Hoffmann G.F. Congenital neurotransmitter disorders. A clinical approach - New York: Nova Biomedical, 2014. - 1st Ed.

22. Jaggi L. et al. Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency // Mol. Gen. Metab. - 2008. - Vol.93. - P.295-305.


Review

For citations:


Pichkur N.A., Ol`khovich N.V., Trofimova N.S. Inborn disorders of tetrahydrobiopterin metabolism: clinical features and diagnosis. Medical Genetics. 2017;16(7):36-41. (In Russ.)

Views: 1157


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7998 (Print)